<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:hpo ids='HP_0001513'>Obesity</z:hpo> and associated pathologies are major global health problems </plain></SENT>
<SENT sid="1" pm="."><plain>Transforming growth factor-β/Smad3 signaling has been implicated in various metabolic processes, including adipogenesis, insulin expression, and pancreatic β-cell function </plain></SENT>
<SENT sid="2" pm="."><plain>However, the systemic effects of Smad3 deficiency on <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in vivo remain elusive </plain></SENT>
<SENT sid="3" pm="."><plain>This study investigated the effects of Smad3 deficiency on whole-body <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="23" ids="18059">lipid</z:chebi> homeostasis and its contribution to the development of <z:hpo ids='HP_0001513'>obesity</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>RESEARCH DESIGN AND METHODS: We compared various metabolic profiles of Smad3-knockout and <z:mp ids='MP_0002169'>wild-type</z:mp> mice </plain></SENT>
<SENT sid="5" pm="."><plain>We also determined the mechanism by which Smad3 deficiency affects the expression of genes involved in adipogenesis and metabolism </plain></SENT>
<SENT sid="6" pm="."><plain>Mice were then challenged with a high-fat diet to study the impact of Smad3 deficiency on the development of <z:hpo ids='HP_0001513'>obesity</z:hpo> and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Smad3-knockout mice exhibited diminished <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> with <z:mp ids='MP_0005292'>improved glucose tolerance</z:mp> and insulin sensitivity </plain></SENT>
<SENT sid="8" pm="."><plain>Chromatin immunoprecipitation assay revealed that Smad3 deficiency increased CCAAT/enhancer-binding protein β-C/EBP homologous protein 10 interaction and exerted a differential regulation on proliferator-activated receptor β/δ and proliferator-activated receptor γ expression in adipocytes </plain></SENT>
<SENT sid="9" pm="."><plain>Focused gene expression profiling revealed an altered expression of genes involved in adipogenesis, <z:chebi fb="23" ids="18059">lipid</z:chebi> accumulation, and fatty acid β-oxidation, indicative of altered adipose <z:mp ids='MP_0001532'>physiology</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>Despite reduced physical activity with no modification in food intake, these mutant mice were resistant to <z:hpo ids='HP_0001513'>obesity</z:hpo> and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> induced by a high-fat diet </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Smad3 is a multifaceted regulator in adipose <z:mp ids='MP_0001532'>physiology</z:mp> and the pathogenesis of <z:hpo ids='HP_0001513'>obesity</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, suggesting that Smad3 may be a potential target for the treatment of <z:hpo ids='HP_0001513'>obesity</z:hpo> and its associated disorders </plain></SENT>
</text></document>